INBX Secondary Offering
Resolves: Announcement of a secondary offering or other dilutive event.
sec_filing· Financial
INBX Secondary Offering
Market overview
Derived from Inhibrx Biosciences, Inc. (INBX) (CIK 0002007919) 8-K filing analysis
Financial prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2027-03-31
About this prediction
Resolution criteria
Announcement of a secondary offering or other dilutive event.
More Financial markets
- Acquisition Integration and Synergies — 75% Yes
- Adherence to U.S. GAAP Standards — 75% Yes
- Revenue Growth from Announced Deal — 70% Yes
- NAV per Share Growth — 75% Yes
- Navan, Inc. Revenue Growth Projection — 75% Yes
- Luminar Technologies: Positive Net Income in 2026 — 75% Yes
- IVVD Merger Synergy Realization — 65% Yes
- Dilution Control — 70% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…